Enhanced Surveillance of Invasive Pneumococcal Disease (IPD)

The HPA is undertaking enhanced surveillance of invasive pneumococcal disease (IPD).  All isolates from IPD, irrespective of patient age should be referred, for serotyping, to the HPA pneumococcal reference laboratory.

Following the announcement of the introduction of PCV in the Routine Childhood Immunisation programme the HPA will be undertaking enhanced surveillance and further investigations of all cases of IPD in children eligible for routine or catch up immunisation. 

The clinical management protocol for the enhanced surveillance is available below:

• Protocol For The Clinical Management Of Cases Of Invasive Pneumococcal Disease (IPD) In Children Targeted For Routine Or Catch-Up Vaccination With Pneumococcal Conjugate Vaccine (Prevenar) (Word Document, 112 KB)
  
  

To send a sample in for serotyping, please use the document below to obtain the necessary form:

• R3 Streptococcus & diphtheria referral form (PDF, 349 KB)
  Streptococcus & diphtheria reference unit form - WHO Collaborating Centre - December 2010
  
  

Last reviewed: 3 September 2008